PA (also known as transthyretin) is also secreted by the liver and has been widely mentioned in predicting early cognitive deficits in AD (Tien et al., 2019) and as a target of cognitive interventions (Saponaro et al., 2020). Here, TTR is linked to Alzheimer disease.